Table 1.
Participant Demographics and Group Means (SD)
| Group | Participant Number | Gender | Age (Years) | Age of First Cl (Years) | SES (out of 64) | Device | Side of Implant | Current Contralateral Hearing Aid Use | Etiology of Hearing Loss | Duration of Hearing Loss (Years) | Better Ear PTA (dB HL) | PRESTO Score (% Correct Keywords) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HiPRESTO | 1 | M | 61 | 55 | 24 | Cochlear | Right | Yes | Unknown | 16 | 111.25 | 76.61 |
| HiPRESTO | 2 | M | 70 | 68 | 42 | Cochlear | Left | Yes | Unknown, progressive loss as adult | 30 | 93.75 | 76.61 |
| HiPRESTO | 3 | F | 67 | 58 | 9 | Cochlear | Bilateral | No | Genetic, Meniere’s disease | 31 | 120.00 | 79.03 |
| HiPRESTO | 4 | M | 55 | 50 | 30 | Cochlear | Bilateral | No | Unknown, progressive loss as an adult | 34 | 120.00 | 79.84 |
| HiPRESTO | 5 | M | 66 | 60 | 18 | Cochlear | Left | No | Meniere’s disease | 52 | 80.00 | 81.25 |
| HiPRESTO | 6 | F | 57 | 48 | 25 | Cochlear | Right | Yes | Genetic, progressive loss as child/adult | 50 | 82.50 | 81.45 |
| HiPRESTO | 7 | M | 59 | 57 | 24 | Cochlear | Bilateral | No | Sudden loss | 4 | 120.00 | 84.38 |
| HiPRESTO | 8 | F | 45 | 44 | 30 | Advanced Bionics | Right | Yes | Unknown, progressive loss as child | 39 | 88.75 | 84.68 |
| HiPRESTO | 9 | F | 65 | 54 | 24 | Cochlear | Bilateral | No | Genetic | 24 | 120.00 | 86.61 |
| HiPRESTO | 10 | F | 66 | 62 | 35 | Cochlear | Right | Yes | Genetic, progressive loss as adult, noise exposure, sudden loss in the right ear | 31 | 78.75 | 88.84 |
| HiPRESTO | 11 | F | 50 | 35 | 33 | Bilateral | No | Unknown, progressive loss as child | 50 | 117.50 | 95.16 | |
| HiPRESTO Mean (SD) | 60.1 (7.8) | 53.7 (9.1) | 26.7 (8.8) | 32.8 (14.8) | 102.95 (18.06) | 83.1 (5.6) | ||||||
| LoPRESTO | 1 | M | 76 | 74 | 35 | Cochlear | Left | Yes | Ototoxicity (amikacin) | 53 | 96.25 | 4.02 |
| LoPRESTO | 2 | F | 52 | 46 | 42 | Cochlear | Right | Yes | Unknown, born with HL | 52 | 113.75 | 22.58 |
| LoPRESTO | 3 | M | 60 | 52 | 36 | Cochlear | Bilateral | No | Measles | 54 | 105.00 | 25.81 |
| LoPRESTO | 4 | M | 59 | 54 | 6 | Cochlear | Right | No | Genetic | 44 | 108.75 | 29.84 |
| LoPRESTO | 5 | F | 55 | 44 | 15 | Cochlear | Left | No | Sudden, otosclerosis, progressive as adult | 30 | 120.00 | 32.26 |
| LoPRESTO | 6 | M | 81 | 80 | 49 | Cochlear | Left | Yes | Unknown, progressive as adult | 13 | 75.00 | 33.06 |
| LoPRESTO | 7 | F | 64 | 59 | 24 | Cochlear | Left | Yes | Unknown, progressive as child | 55 | 95.00 | 33.87 |
| LoPRESTO | 8 | F | 62 | 59 | 14 | Cochlear | Bilateral | No | Sepsis, ototoxicity | 4 | 95.00 | 34.68 |
| LoPRESTO | 9 | F | 76 | 68 | 30 | Cochlear | Left | No | Progressive loss as adult, probable autoimmune | 31 | 108.75 | 37.05 |
| LoPRESTO | 10 | F | 65 | 63 | 36 | Cochlear | Right | No | Genetic, progressive as adult | 59 | 86.25 | 41.94 |
| LoPRESTO Mean (SD) | 65.0 (9.6) | 59.9 (11.7) | 28.7 (13.7) | 39.5 (19.2) | 100.38 (13.51) | 29.5 (10.5) |
F = female; M = male; PTA = pure-tone average.